Brind.

Nanobiotix and Jason Chan presented study results at the European Society for Medical Oncology (ESMO) meeting.

1 report, 1 independent Updated Oct 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Nanobiotix European Society for Medical Oncology

Keep exploring

The entities involved

Nanobiotix
French healthcare company

Nothing else this week.
European Society for Medical Oncology
Professional organisation
- AstraZeneca presented trial results for its IMFINZI cancer treatment at the European Society for Medical Oncology (ESMO) Congress in Madrid.Mon 01:52

Related events

Study results were presented by Tempus and Pfizer at the ESMO Congress, focusing on ongoing collaboration regarding diagnostic barriers.Oct 19
Researchers presented Phase 3 clinical data at the European Society for Medical Oncology (ESMO) Congress on September 21, 2026.Sep 21

Coverage

Newest first; wire copies grouped

Oct 24manilatimes.net